Definiens Cellenger: flexible and platform-independent enterprise solution automates and standardizes cell image analysis tailored to specific assays
Munich, Germany and Vienna, Austria – November 6, 2006 - Definiens AG, the number one Enterprise Image Intelligence solution provider, today introduced Definiens Cellenger® v1.4. It is being announced at the High-Content Analysis Europe, November 6-8, Vienna, the most promising European event of the year focusing on high-content cellular assays for compound screening and pathway analysis. The new version of Definiens Cellenger is designed to help pharmaceutical and biotechnology companies analyze automated cell-based assays from any source, creating a deeper understanding of image data. It provides a simple yet flexible environment to support and accelerate the drug development process across the entire enterprise. Definiens Cellenger v1.4 is available immediately.
Built on the Definiens Cognition Network Technology™, Definiens Cellenger enables these organizations to go beyond the simple measurement of objects by shape and intensity to the quantification of complex relationships between objects, revealing subtle biological effects. It enables much deeper understanding of image data and complements all workflows, whether they be assay development, screening or informatics. Definiens Cellenger is the first true platform-independent high-content analysis software, bridging the gaps between different vendors and platforms offering an unbiased and objective view of the data. It allows standardization of assays across the enterprise, consolidating training and expertise as well as knowledge to be transferred seamlessly between work groups.
Definiens Cellenger contains highly robust detection and classification algorithms which provide accurate multi-dimensional segmentation of objects, even with heterogeneous cell populations or of imperfect images that were taken under poor conditions. Multiple image analysis experiments can be performed in parallel and export data can be configured to contain the results of one experiment conditional to the results of another. This leads to much higher data confidence levels.
"Definiens Cellenger enables you to go beyond traditional assay development; it gives you faster results and better insight into any biological question you have; independent of platform, assay complexity, and type of stain," said Dr. Wolfgang Rencken, Vice President Technology and Products at Definiens AG. "It is built to meet the needs of the most demanding global organizations."
Definiens Cellenger has open interfaces and formats and, as with all Definiens® products, is designed to seamlessly integrate within existing technology infrastructures, complementing rather than replacing existing investments in software and hardware.
Definiens Cellenger version 1.4 - new features include:
» Modifiable pre-defined solutions for common assay tasks
» New detection, measurement and export actions
» Training based classification
» Plate based statistics and quality control metrics
» Full customization and extension of the Cellenger library
» Tightly integrated data representations
» More seamless support and a wider range of image acquisition systems
» Support for metadata import and use within analysis process.
» Server processing on Linux
A datasheet covering the technical details and all new features of Definiens Cellenger v1.4 is available upon request.
About Definiens AG
Definiens is the number one provider of Enterprise Image Intelligence solutions. Leading corporations deploy Definiens' solutions across their organizations to automate image-intensive business processes. Definiens' clients enjoy high return on investments by significantly reducing the cost and risk of image-related information, enabling higher quality decisions faster, speeding time-to-market.
Definiens' products and solutions are built on its platform technology Definiens eCognition™ that represents a quantum leap in digital image analysis. The advanced and robust image analysis solutions classify images more intelligently, more accurately, and more efficiently than traditional methods. Definiens concentrates on the Life Sciences and Earth Observation/Remote Sensing markets. The Definiens technology is used to accelerate the drug discovery, development, and diagnostics processes and also enables satellite and aerial image classification. In Life Sciences, Definiens helps address a wide range of challenges including analysis of cells in High Content Screening, detailed quantitative analysis of structure in tissue, normal and abnormal screening in toxicological pathology and interpretation of 3D data in radiology.
Definiens is headquartered in Munich, Germany and has offices located in the USA and Europe. Further information is available at www.definiens.com.
Press contacts:
Definiens AG
Rene Hermes, Vice President Marketing
rhermes@definiens.com
+49 (0)89 231180-11
Lucy Turpin Communications GmbH
Nina Wenske, PR & MarCom Manager
definiens@lucyturpin.com
+49 (0)89 417761-13
| 
